Fig. 2
From: ADAR1 overexpression is associated with cervical cancer progression and angiogenesis
Overall survival curve of patients with ADAR1 positive and ADAR1 negative cervical squamous cell carcinoma. Survival time of ADAR1 positive group was 38.252 ± 1. 301 month, survival time of ADAR1 negative group was 45.458 ± 0. 863 months. The difference was statistically significant (χ2 = 5.101, p = 0.024). 0 = ADAR1 negative group; 1 = ADAR1 positive group